Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GLSI · against 272 other Healthcare companies of similar size
Ranked #174 of 273 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score100 peers with a valuation score of 0–9, including GLSI · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | GLSI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 256 reported | -10.0% | -0.6% | 36% | 30% | |
| EBITDA yieldHigher is better · 278 reported | -10.1% | 1.5% | 26% | 50% | |
| Free cash flow yieldHigher is better · 149 reported | -5.3% | -10.1% | 64% | 20% | |
| Book yieldHigher is better · 259 reported | 1.3% | 59.4% | 7% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 174 | 302M USD | 8 | 17 | |
| 174 | 455M USD | 8 | 36 | |
| 174 | 375M USD | 8 | 46 | |
| 174 | 221M USD | 8 | 33 | |
| 174 | 234M USD | 8 | ||
| 174 | 207M USD | 8 | 41 | |
| 174 | 238M USD | 8 | 41 | |
| 174 | 172M USD | 8 | 3 | |
| 174 | 275M USD | 8 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score